baber/WOPTO huggingface dataset:
Patent JP-2001503307-A (JP)
IPC: A61B10/00
Filed: 1998-04-09
Abstract: An apparatus and method to assess cardiac function in a human has a sensing mechanism to be positioned on the thyroid cartilage in the neck against the trachea. The sensing mechanism is able to sense a response of the thyroid cartilage to heart function. The apparatus includes a restraining system to hold the sensing mechanism in position. The method of determining cardiac function comprises sensing the response of the thyroid and trachea to heart function.
Patent JP-2001522409-A (JP)
Title: チタン結晶及びチタン
IPC: C25C3/28
Filed: 1998-04-30
Abstract: (57)【要約】
高純度チタン製造のための方法及び装置、並びにそれらに依って製造された高純度チタンが記載される。そのプロセスは容器中でチタンスポンジを製造し、同容器中でその場でチタン溶融塩電解することによって、高純度のチタン結晶を作るもので、特に低酸素を希望する場合は、この様にして製造された高純度チタン結晶を沃素で処理する。
Patent JP-2001523379-A (JP)
Title: 周囲により引き起こされた結像悪化を補償する、描写および／または走査装置
IPC: H01J37/02
Filed: 1998-04-29
Abstract: (57)【要約】
結像を悪化し得る周囲の影響を補償するための補償装置、ある対象の少なくとも一つの像点を認識する画像認識装置、画像認識装置に続いて接続した画像処理装置、並びに画像表示装置、さらに少なくとも一つの電気フィルタ、およびアクチュエータおよび／または操作端を含む、描写するおよび／または走査モード中で走査する装置、特に走査顕微鏡が述べられる。その際周囲の影響に依存する第一信号がフィルタを通り、結像および／または画像表示に影響を及ぼすアクチュエータおよび／または操作端に向うので、フィルタの伝送特性の調整により特徴づけられた装置の校正された状態では、画像悪化は著しく減少する。
Patent JP-2002505595-A (JP)
IPC: A61B90/00
Filed: 1998-05-07
Abstract: The invention relates to a device for performing endoscopic guided fine needle biopsy, in which the needle is automatically controlled by using a pre-biased needle. Upon release of a spring, the needle projects toward tissue, overcoming frictional forces, thanks to high acceleration. This reduces the danger of breaking the needle.
Patent JP-2001525991-A (JP)
Title: 制御された劈開プロセス
IPC: H01L27/12
Filed: 1998-05-11
Abstract: (57)【要約】
ドナー基体（10）から材料フィルム（12）を形成する技術である。この技術はドナー基体（10）の表面を通って、表面の下方の選択された深さ（20）へ選択された方法によりエネルギを有する粒子（22）を導入するステップを有し、粒子は選択された深さよりも上にドナー基体材料（12）を限定するため比較的高い濃度と選択された深さにおけるパターンの粒子を有する。加圧された流体のようなエネルギソースはドナー基体の選択された領域に導かれて、選択された深さ（20）で基体（10）の制御された劈開動作を開始し、劈開動作はドナー基体の残りの部分からドナー材料を分離するため拡張した劈開フロントを与える。
Patent MD-20020139-A (MD)
Title: Pharmaceutical compositions for treatment of cephalalgia, migraine, nausea and vomiting
Inventor: MIRIMSKY ALEXANDER
IPC: A61K33/42
Filed: 2001-08-30
Abstract: It is disclosed utilization of S-alkyl isothiouronium, not limiting oneself to the utilization of the preferable compound of diethyl phosphate S-ethyl isothiouronium, for treatment of cephalalgia, in particular of migraine, as well as for prevention and treatment of nausea and vomiting. The compositions described in the description are efficient in the prevention and attenuation of the vomiting associated with migraine or with certain methods of treatment, such as chemotherapy or radiotherapy, as well as with other symptoms of migraine, including phonophobia and photophobia. Claims: 47
Patent MX-157500-A (MX)
Inventor: VOBLER WILLIAM EDWARD JR
IPC: F28F1/14
Filed: 1982-02-09
Abstract: An atmospheric vaporizer suitable for vaporizing cryogenic liquids on a continuous basis at greatly improved operating efficiency characterized by a critical pass spacing ratio of from 1 to 5.
Patent NZ-200519-A (NZ)
Title: Sustained release pellet containing indoramin
Inventor: MUGHAL A S
IPC: A61K31/445
Filed: 1982-05-04
Abstract: The invention provides a sustained release pharmaceutical composition comprising a mixture of micronised indoramin or a pharmaceutically acceptable salt thereof, a water-channelling agent and a wetting agent, the mixture being in the form of a non-compressed pellet and having an enteric coat or a sustained release coat permeable to gastrointestinal juices. Sustained release capsules are also provided comprising a plurality of the aforementioned pellets.
Patent NZ-204839-A (NZ)
Title: Oven for baking bread having a serpentine conveyor path with various temperature levels
Inventor: HICKS K J
IPC: F27B9/14
Filed: 1983-07-07
Abstract: An oven which is suitable for use in baking bread and which incorporates a baking chamber through which an endless conveyor is driven for transporting product support trays into, through and from the chamber. The conveyor enters the lower region of the chamber, exits from an upper region of the chamber and makes a plurality of horizontal passes in ascending through the chamber. A bank of controller regulated heating elements is located between each of the horizontal passes of the conveyor but tunnels are provided in the lower region of the chamber to prevent heat from being radiated downwardly onto the product support trays during their initial stage of conveyance through the chamber.
Patent NZ-207005-A (NZ)
Title: Continuous business form assembly providing combined mailers and top opening return envelopes
Inventor: SIMMONS R D
IPC: B42D5/02
Filed: 1984-02-01
Abstract: A continuous business form assembly including combined mailers and return envelopes is compatible with automatic, non-adjustable slitters.
Patent NZ-228254-A (NZ)
Title: Cephalosporin derivatives and phamaceutical compositions: processes for preparation
Inventor: KAZUO SAKANE
IPC: C07D519/00
Filed: 1989-03-07
Abstract: A compound of the formula : <CHEM>  wherein R<1> is amino or a protected amino group,  R<2> is an organic group, R<3> is hydrogen, lower alkyl, hydroxy(lower)alkyl, protected hydroxy(lower)alkyl, amino(lower)alkyl, protected amino(lower)alkyl or an imino protective group,  R<4> is hydrogen, lower alkyl or lower alkylthio, A is lower alkylene which may be substituted with suitable substituent(s) and  Z is N or CH, and a pharmaceutically acceptable salt thereof, processes for its preparation and pharmaceutical compositions comprising them or a pharmaceutically acceptable salt thereof in admixture with pharmaceutically acceptable carriers.
Patent NZ-230374-A (NZ)
Title: Amino-substituted isoquinuclidine quinolone derivatives
Inventor: KLEINMAN EDWARD FOX
IPC: C07D453/06
Filed: 1989-08-21
Abstract: Compounds of the formula <CHEM> wherein R<1> is hydrogen, C1-C6 alkyl, or a pharmaceutically acceptable cation; Y is cyclopropyl, ethyl or p-fluorophenyl, and X is hydrogen or fluoro, or X and Y taken together form a group <CHEM> wherein R<3> is hydrogen or C1-C4 alkyl; or a pharmaceutically acceptable salt thereof, have antibacterial properties.
Patent NZ-236554-A (NZ)
Title: 2-formylbenzyl phosphonic acid derivatives and pharmacetical compositions
Inventor: PEYMAN ANUSCHIRWAN
IPC: C07F9/653
Filed: 1990-12-19
Abstract: The compound of the formula I <IMAGE> in which R represents an aldehyde group or a group which can be converted into an aldehyde, R<1> and R<2> represent alkyl, alkenyl, alkynyl, aralkyl, cycloalkyl, hydrogen, sodium, potassium, calcium, magnesium, aluminium, lithium, ammonium or triethylammonium or  R<1> and R<2> together form a cyclic diester, R<3> and R<4> represent alkyl, alkenyl, alkynyl, cycloalkyl, hydrogen, alkoxy or halogen, R<5> and R<8> represent alkyl, alkenyl, alkynyl, aralkyl, cycloalkyl, alkoxy, phenyl, cyanide, hydroxyl or hydrogen, X, Y or Z represent oxygen or sulphur, or prodrug forms of the compound of the formula I can be used for treatment of diseases caused by viruses. The preparation of these compounds and pharmaceutical preparations which contain them and also their use are described.
Patent NZ-237669-A (NZ)
Title: T-cell proteins expressed in t-cell development and their preparation
Inventor: MACLEOD CAROL L
IPC: A61P37/00
Filed: 1991-04-03
Abstract: The present invention provides novel DNA sequences, recombinant DNA (rDNA) molecules, processes for producing novel T-cell proteins expressed in T-cell development, the novel T-cell proteins in substantially pure form and antibodies which bind to the novel proteins. More particularly, it relates to novel DNA sequences expressed in appropriate hosts and the novel T-cell proteins produced in these hosts. The present invention also provides novel transmembrane proteins in substantially pure form, rDNA molecules encoding transmembrane proteins and processes for producing the novel transmembrane proteins. The DNA sequences and recombinant DNA molecules of this invention are characterized in that they are expressed by T lymphoma cells and have at least one of the following characteristics: (1) is expressed in normal thymus, activated spleen cells, or gut associated lymphoid tissue, (2) is expressed in ovarian tissue, normal liver and/or in a stage specific manner in embryonic development and (3) encode novel transmembrane proteins having multiple membrane spanning domains.
Patent NZ-243881-A (NZ)
Title: Paperboard carton and single blank for making same; cutout slots with cuts in top panels for carrying
Inventor: CAMPBELL GEOFFREY
IPC: B65D/
Filed: 1992-08-07
Abstract: PCT No. PCT/GB92/01472 Sec. 371 Date May 5, 1994 Sec. 102(e) Date May 5, 1994 PCT Filed Aug. 7, 1992 PCT Pub. No. WO93/02944 PCT Pub. Date Feb. 18, 1993.There is provided a carton 11 for holding a number of articles 34. There is a bottom panel 12, two side walls 13, 14, end panels 17 and overlapping top panels 26, 28. The overlapping portions of panels 26, 28 are glued together and there is a cut-out portion 30 in the outer top panel 26. The cut-out portion 30 lies adjacent the overlapping portions and midway between the carton ends.
Patent NZ-245197-A (NZ)
Title: Method of improving fish production by administration of ractopamine
Inventor: ANDERSON DAVID BENNETT
IPC: A23K1/16
Filed: 1992-11-20
Abstract: This invention is directed to the use of the compound ractopamine for improved production of fish.
Patent NZ-250523-A (NZ)
Title: Mixture of polyurethanes having at least two end groups, the two end groups being isocyanate-polyether adducts, isocyanate-nonfunctional group adducts or mixtures of both where the nonfunctional group is not a polyether
Inventor: EISENHART ERIC KARL
IPC: A61K8/00
Filed: 1993-12-20
Abstract: A mixt. of polyurethanes comprises a first polyurethane with at least two end gps., each comprising a terminal isocyanate and a polyether; a second polyurethane with at least two end gps., each comprising a terminal isocyanate and a non-function gp.; and a third polyurethane with at least two end gps., one comprising a terminal isocyanate and a polyether and the other a terminal isocyanate and a non-fuctional gp. An aq. compsn. pref. comprises 0.005-20 wt.% of the polyurethane mixture. Also claimed is a mixt. of polyurethanes comprises a polyurethane contg. two end gps., one of which comprises a terminal isocyanate and a polyether and the other of which comprises a terminal isocyanate and a non-functional gp. Pref., the polyether is an alkyl or aryl polyether alcohol, esp. polyethylene glycol methyl ether or polypropylene glycol methyl ether. The non-functional gp. is derived from 1-octa-decanol. The three polyurethanes are present in amts. of 8.3-25, 25-75 and 16.7-50 mole %, esp. 12.5-25, 25-62.5 and 25-90 mole %.
Patent NZ-259788-A (NZ)
Title: Coating composition, for confectionery products, comprising a diacetin fat and a crystal modifying fat
Inventor: WHEELER EDWARD L
IPC: A23L25/00
Filed: 1993-12-16
Abstract: The physical properties of diacetin fats such as diacetopalmitin, diacetostearin, and diacetoarachidin, diacetobehenin are modulated by mixing them with about 10% to about 16% crystal modifier fats that are triglycerides bearing one short C2 to C4 acid residue and two long, saturated C16 to C22 fatty acid residues per molecule. The modified diacetin fats, which exhibit improved snap, gloss, hardness, bloom resistance, and mold release, are suitable for use in edible coatings, especially confectionery coatings.
Patent NZ-259857-A (NZ)
Title: Transdermal therapeutic system; comprises galanthamine and an adhesive reservoir layer including polyacrylates
Inventor: HILLE THOMAS
IPC: A61K9/70
Filed: 1994-01-10
Abstract: PCT No. PCT/EP94/00054 Sec. 371 Date Sep. 29, 1995 Sec. 102(e) Date Sep. 29, 1995 PCT Filed Jan. 10, 1994 PCT Pub. No. WO94/16707 PCT Pub. Date Aug. 4, 1994A transdermal therapeutic system (TTS) for the administration of galanthamine to the skin each system having a backing layer which is impermeable to active substances and a pressure sensitive adhesive reservoir layer, wherein the reservoir layer comprises 40-80% wt. polymeric material selected from the group consisting of polyacrylates, 0.1-30%-wt. plasticizers, and 0.1-30%-wt. galanthamine base or one of its pharmaceutically acceptable salts.
Patent NZ-290989-A (NZ)
Title: Biocompatible telo-collagen polymers; preparation and use for optical lenses
Inventor: FEINGOLD VLADIMIR
IPC: C08H1/06
Filed: 1995-07-21
Abstract: The present invention is biocompatible polymer containing the copolymerization product of a mixture of hydrophobic and hydrophilic acrylic and/or allelic monomers, graft-polymerized with telo-collagen. The present material is useful in the production of deformable lenses, for example, intraocular lenses, refractive intraocular contact lenses, and standard contact lenses useful, for example, for correcting aphekia, myopia and hypermetropia.
Patent NZ-294007-A (NZ)
Title: Paperboard interlock arrangement for connecting two pieces of paperboard comprising projecting portions on one flap and openings in the other flap
Inventor: BRIAND NATHALIE
IPC: B65D71/00
Filed: 1995-10-17
Abstract: PCT No. PCT/GB95/02448 Sec. 371 Date Jun. 3, 1997 Sec. 102(e) Date Jun. 3, 1997 PCT Filed Oct. 17, 1995 PCT Pub. No. WO96/12656 PCT Pub. Date May 2, 1996An interlocking paperboard carton blank (10) is disclosed. The carton blank has at least one flap (19) projecting from a side dge of a first base panel (14), the flap having a leading portion (20) which is folded about a scored waist section score line (23) back onto the remainder of the flap to double the thickness of the flap. The leading portion of the flap includes at least one, and preferably two laterally projecting portions (21). The flap is inserted folded end first into at least one correspondingly positioned opening (27) defined in a second base panel (15) of the carton blank. The flap is passed into the opening until the two lateral projections of the folded flap are passed through the opening in the second base panel, whereupon the laterally projecting portions are constructed and arranged to be urged upwardly from the remainder of the flap so as to prevent withdrawal of the flap from the opening while the leading portion of the flap remains folded against the remainder of the flap to ensure that the flap has a doubled thickness in the interlocked base panels of the carton blank.
Patent NZ-294568-A (NZ)
Title: Cyanine dyes containing indole moieties(or analogues);in vivo diagnostic method using a dye having an absorption maxima of 650-1200nm (near infrared) optionally conjugated with a biological molecule
Inventor: LICHA KAI
IPC: C07D209/60
Filed: 1995-10-10
Abstract: A process for in vivo diagnosis using near infra red (NIR) irradiation is claimed. The process uses dyestuffs or their derivs. of formula Bl-(F-Wn)m (I) or their physiologically acceptable salts. l = 0-6; n = 0-10; m = 1-100; B = a biological diagnostic unit of mol. wt. up to 30000 which binds on certain cell populations or which binds specifically to receptors or which enriches in tissues or tumours or which remains largely in the blood; or B = a non-specifically binding macromolecule; F = a dyestuff which has an absorption maximum 650-1200 nm; W = a hydrophilic gp. which improves water solubility. (I; l = 0) has an n-octanol-water partition coefficient less than or equal to 2.0. Also claimed are cyanine dyestuffs of formula (V) and their salts. Q = =CH-C(R30)=CH-, =CH-CH=C(R30)-CH=CH-, or a gp. of formula (a) or (b); R30 = H, OH, COOH, 1-4C alkoxy or Cl; b=2-3; R31 = H or 1-4C alkyl; X, Y = O, S, CH=CH or C(CH2R32)(CH2R33); R, R1-R9, R32, R33 = R' or R"; or adjacent pairs of R-R7 may combine to form a 5-6 membered aromatic or saturated annelated ring; R' = H, OH, COOH, SO3H, up to 10C carboxyalkyl, up to 10C alkoxycarbonyl, up to 10 C alkoxyoxoalkyl or 1-4C sulphoalkyl; R" = a non-specific macromolecule or (O)v-(CH2)o-CONR34-(CH2)s-(NHCO)q-R35; o, s = 0; or o, s = 1-6; q and v = 0-1; R34 = H or Me; R35 = 1-6C alkyl (substd. with 1-3 carboxy), 6-9C aryl, 7-15C aralkyl, nC alkyl contg. 2 to (n-1) OH gps., or CH2(N(CH2COOH)CH2CH2)yN(CH2COOH)2; n = 3-6; y = 1 or 2; provided that if X and Y = O, S, CH=CH or CMe2, then at least one of R-R9 = R" and q = 1.
Patent NZ-330100-A (NZ)
Title: method of preparing a mould growth inhibiting product by mixing azodicarbonamide with a mould growth inhibitor and then heating the product to decompose the azodicarbonamide
Inventor: KUHN DALE F
IPC: A21D2/24
Filed: 1998-03-31
Abstract: A method of preparing a mould growth-inhibiting product for foodstuffs is claimed comprising: a) placing a layer of azodicarbonamide on a substrate; b) covering the layer of step a) with a gas permeable separator; c) superimposing a layer of a second compound selected from benzoic acid, salts of benzoic acid, paraben, acetic acid, salts of acetic acid, lactic acid, fumaric acid, sorbic acid, salts of sorbic acid, propionic acid, salts of propionic acid or mixtures thereof to form a tri-layered combination and d) heating the tri-layered combination to a sufficient temperature for a sufficient time to form the mould growth-inhibiting product  with no off-flavour, off-odour, off-texture or off-colour. Addition to 311890
Patent NZ-335609-A (NZ)
Title: Purified or recombinant mammalian DVic-1 controlling development, differentiation, trafficking and physiology of cells
Inventor: VICARI ALAIN
IPC: A61K38/00
Filed: 1997-11-26
Abstract: Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.     00000
Patent NZ-337070-A (NZ)
Title: Series compensation of electric alternating current machines
Inventor: LEIJON MATS
IPC: H01B7/02
Filed: 1998-02-02
Abstract: Described is a method of series compensating rotating electric alternating current machines (2).  The series is connected, directly or via a static current converter (28), to a three-phase distribution or transmission network (6), wherein the stator winding of the alternating current machine is Y-connected, a capacitive circuit (14) for the fundamental frequency of the voltage is connected in each phase between the down side of the winding and the earth point (20) of the distribution or transmission network (6). A device for such series compensation comprises a capacitive circuit (14) for the fundamental frequency of the voltage, connected between the down side of the winding and the earth point (20) of the distribution or transmission network (6).
Patent NZ-337348-A (NZ)
Title: Elongated tubular product, in particular an installation conduit
Inventor: BLANC CHRISTIAN
IPC: H02G9/06
Filed: 1998-03-13
Abstract: Provided is an elongated tubular product with a uniform cross section along its whole length, comprising a solid tube (1) made of at least a plastics material, both sufficiently flexible to be wound and unwound, and sufficiently rigid to resist a centripetal or centrifugal radial force, said solid tube comprising, on the inside and/or on the outside, a surface coating (3) whose free surface constitutes a friction surface and comprising a plastic matrix in which is distributed a lubricant. The tube is characterised in that, with synergistic effect, the particles of a solid lubricant (4) are distributed in the plastic matrix, at least partly flush at the free surface of the surface coating, and a liquid lubricant, compatible with the plastic matrix, is dispersed in the surface coating, practically without wetting the free surface of the latter.
Patent NZ-500258-A (NZ)
Title: Infrared transmission amplitude increased if transmitted signal not at first received
Inventor: KAWAI EIJI
IPC: H04B10/10
Filed: 1999-10-12
Abstract: Communicating modules effect bi-directional transmission using infrared signals so as not to cause undue interference with other communicating modules.  A module transmits at a low level and if a second module does not respond to the transmitted signal within a predetermined time of the first transmission, the module retransmits the signal at a greater intensity.  The cycle is repeated until an adequate communication is established between the modules with the transmissions being at the lowest acceptable intensity level.  The technique is particularly directed to communication between portable game station modules to prevent interference between communications of several modules and to conserve battery power of the modules.
Patent NZ-502178-A (NZ)
Title: Fumonisin detoxification compositions
Inventor: DUVICK JONATHAN
IPC: C12N15/82
Filed: 1998-07-07
Abstract: Methods for identifying organisms capable of degrading fumonisin. Fumonisin can be incorporated into culture medium for selection of organisms resistant to fumonisin and/or capable of growing on fumonisin as a sole carbon source. Using this method, several organisms have been identified. These organisms can be used to isolate the enzymes and the genes responsible for conferring fumonisin-resistance. The gene can be cloned and inserted into a suitable expression vector so that the protein can be further characterized. Additionally, the DNA encoding for fumonisin degrading enzymes can be used to transform plant cells normally susceptible to Fusarium or other toxin-producing fungus infections. Plants can be regenerated from the transformed plant cells. In this way, a transgenic plant can be produced with the capability of degrading fumonisin, as well as with the capability of producing the degrading enzymes.
Patent NZ-502304-A (NZ)
Title: Harmonic compensation apparatus and methods with three level inverter
Inventor: TUCK COLIN JOHN
IPC: H02J3/01
Filed: 1998-06-15
Abstract: A parallel connected active harmonic compensator is disclosed having a three level inverter (14) to provide the power stage for supplying or drawing current to or from a line of an AC power distribution system to compensate for harmonics drawn by a load (RL) supplied by the line. The active harmonic compensator compensates for one or more harmonic components by deriving a control signal which is substantially devoid of the relevant harmonic components, generates predetermined boundaries relative to the control signal and used the boundaries to control the inverter switches (14) to supply or draw current to or from the line to remove the relevant harmonic components.
Patent NZ-506866-A (NZ)
Title: Bioactive whey protein hydrolysate free of bitter flavours wherein the enzyme used is a heat labile protease
Inventor: SCHLOTHAUER RALF-CHRISTIAN
IPC: A23L1/305
Filed: 2000-09-11
Abstract: A process for preparing a whey protein hydrolysate containing bioactive peptides is described.  The process comprises hydrolyzing a whey protein isolate (WPI) with one or more enzymes characterised in that: (i) the enzyme is selected from the group consisting of Protease P6, Protease A, Protease M, Peptidase, Neutrase, Validase, AFP 2000, and any other heat labile protease; (ii) the hydrolysis is carried out at a temperature of between 30oC and 65oC at a pH of about 3.5 to 9.0 when the enzyme is a neutral protease, at a pH of about 2.5 to 6.0 where the enzyme is an acid protease and at a pH of about 5.0 to 10.0 where the enzyme is an alkaline protease; (iii) the hydrolysis is terminated when a degree of hydrolysis of no greater then about 10% has been reached; (iv) the hydrolysis is terminated by deactivating one or more of the enzymes; and (v) the conditions for step (iv) are sufficiently mild to avoid substantial denaturing of peptides or residual proteins in the hydrolysate; wherein the product produced by the process is highly soluble.